BACKGROUND Extant information reveals inconsistencies concerning the natural history,
pathologic features, and treatment of lobular carcinoma in situ (LCIS) of the breast. It is …

BACKGROUND The current report represents a 12‐year clinicopathologic update of an
earlier 5‐year analysis of 180 patients with lobular carcinoma in situ (LCIS) who were …

Background Lobular carcinoma in situ (LCIS) is known to be a risk factor for the
development of invasive breast cancer. Debate continues as to whether LCIS is also a …

The article discusses a survey of self-reported breast surgeons which revealed that there
was no consensus for surgical treatment of Pleomorphic Lobular Carcinoma in Situ (PLCIS) …

BACKGROUND The goals of the current study were to compare the clinicopathologic
presentations of patients with lobular carcinoma in situ (LCIS) as a component of breast …

Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …

This report describes the follow‐up of 108 women who underwent ipsilateral mastectomy for
lobular carcinoma in situ (LCIS). Twenty‐four women found to have concurrent contralateral …

Background: The finding of lobular carcinoma in situ (LCIS) in the breast has generally
prompted treatment with unilateral or bilateral mastectomy. Most experts now feel that LCIS …

BACKGROUND Lobular carcinoma in situ (LCIS) is a known risk factor for the development
of invasive breast carcinoma. However, little is known regarding the impact of LCIS in …

Purpose Lobular carcinoma in situ (LCIS) is a marker of increased risk of breast cancer.
Current guidelines do not recommend mastectomy as a strategy for risk reduction for most …